Propranololo (Italian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Propranololo" in Italian language version.

refsWebsite

Global rank Italian rank

50nih.gov

4^th place

9^th place

15doi.org

2^nd place

7^th place

8oadoi.org

799^th place

22^nd place

5archive.org

6^th place

8^th place

1springerlink.com

2,569^th place

2,344^th place

1tidsskriftet.no

low place

1ctsnetjournals.org

low place

1nejm.org

2,374^th place

1,283^rd place

1jamanetwork.com

2,650^th place

2,089^th place

archive.org

Prichard BN, Ross EJ, Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma, in American Journal of Cardiology, vol. 18, n. 3, settembre 1966, pp. 394-8, PMID 5925096.
Ohrström A, Pandolfi M, Long-term treatment of glaucoma with systemic propranolol, in Am J Ophthalmol, vol. 86, n. 3, settembre 1978, pp. 340-4, PMID 717497.
Goldstein MB, Folsom T, The successful treatment of psychogenic polydipsia and water intoxication with propranolol. A case report, in Minnesota medicine, vol. 74, n. 4, aprile 1991, pp. 29-32, PMID 1875874.
Brunet A, Orr SP, Tremblay J, Robertson K, Nader K, Pitman RK, Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder, in Journal of Psychiatric Research, vol. 42, n. 6, maggio 2008, pp. 503-6, DOI:10.1016/j.jpsychires.2007.05.006, PMID 17588604.
McGhee LL, Maani CV, Garza TH, Desocio PA, Gaylord KM, Black IH, The effect of propranolol on posttraumatic stress disorder in burned service members, in J Burn Care Res, vol. 30, n. 1, gennaio-febbraio 2009, pp. 92-7, PMID 19060728.

ctsnetjournals.org

icvts.ctsnetjournals.org

Mahmoud AB, Tantawy AE, Kouatli AA, Baslaim GM, Propranolol: a new indication for an old drug in preventing postoperative junctional ectopic tachycardia after surgical repair of tetralogy of Fallot (PDF) ^{[collegamento interrotto]}, in Interact Cardiovasc Thorac Surg, vol. 7, n. 2, aprile 2008, pp. 184-7, DOI:10.1510/icvts.2007.160945, PMID 18089616.

doi.org

dx.doi.org

Young R, Glennon RA, S(−)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats (PDF) ^{[collegamento interrotto]}, in Psychopharmacology, vol. 203, n. 2, aprile 2009, pp. 369-82, DOI:10.1007/s00213-008-1317-2, PMID 18795268.
Frank MJ, Abdulla AM, Watkins LO, Prisant L, Stefadouros MA, Long-term medical management of hypertrophic cardiomyopathy: usefulness of propranolol, in European heart journal, vol. 4, suppl. F, novembre 1983, pp. 155-64, DOI:10.1093/eurheartj/4.suppl_F.155, PMID 6686531.
Chew SL, Recent developments in the therapy of phaeochromocytoma, in Expert Opin Investig Drugs, vol. 13, n. 12, dicembre 2004, pp. 1579-83, DOI:10.1517/13543784.13.12.1579, PMID 15566315.
Graham EM, Bandisode VM, Bradley SM, Crawford FA Jr, Simsic JM, Atz AM, Effect of preoperative use of propranolol on postoperative outcome in patients with tetralogy of Fallot, in The American Journal of Cardiology, vol. 101, n. 5, 1º marzo 2008, pp. 693-5, DOI:10.1016/j.amjcard.2007.10.033, PMID 18308023.
Mahmoud AB, Tantawy AE, Kouatli AA, Baslaim GM, Propranolol: a new indication for an old drug in preventing postoperative junctional ectopic tachycardia after surgical repair of tetralogy of Fallot (PDF) ^{[collegamento interrotto]}, in Interact Cardiovasc Thorac Surg, vol. 7, n. 2, aprile 2008, pp. 184-7, DOI:10.1510/icvts.2007.160945, PMID 18089616.
Léauté-Labrèze C et al., Propranolol for Severe Hemangiomas of Infancy (PDF), in New England Journal of Medicine, vol. 358, 24 pagine=2649–2651, giugno 2008, DOI:10.1056/NEJMc0708819, PMID 18550886.
(DE) Kornischka J, Cordes J, Agelink MW, [40 years beta-adrenoceptor blockers in psychiatry], in Fortschr Neurol Psychiatr., vol. 75, n. 4, aprile 2007, pp. 199-210, DOI:10.1055/s-2006-944295, PMID 17200914.
Fleminger S, Greenwood RJ, Oliver DL, Pharmacological management for agitation and aggression in people with acquired brain injury, in Cochrane Database Syst Rev, n. 4, 18 ottobre 2006, DOI:10.1002/14651858.CD003299.pub2, PMID 17054165.
Brunet A, Orr SP, Tremblay J, Robertson K, Nader K, Pitman RK, Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder, in Journal of Psychiatric Research, vol. 42, n. 6, maggio 2008, pp. 503-6, DOI:10.1016/j.jpsychires.2007.05.006, PMID 17588604.
Vaiva G, Ducrocq F, Jezequel K, Averland B, Lestavel P, Brunet A, Marmar CR, Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma, in Biological psychiatry, vol. 54, n. 9, 1º novembre 2003, pp. 947-9, DOI:10.1016/S0006-3223(03)00412-8, PMID 14573324.
Glannon W, Psychopharmacology and memory, in Journal of Medical Ethics, vol. 32, n. 2, pp. 74-8, DOI:10.1136/jme.2005.012575, PMID 16446410.
Ohnishi S, Sadanaga K, Katsuoka M, Weidanz W, Effects of membrane acting-drugs on plasmodium species and sickle cell erythrocytes, in Mol Cell Biochem, vol. 91, n. 1-2, 1990, pp. 159–65, DOI:10.1007/BF00228091, PMID 2695829.
Singh N, Puri S, Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis, in Acta Trop, vol. 77, n. 2, 2000, pp. 185–93, DOI:10.1016/S0001-706X(00)00133-9, PMID 11080509.
Murphy S, Harrison T, Hamm H, Lomasney J, Mohandas N, Haldar K, Erythrocyte G protein as a novel target for malarial chemotherapy, in PLoS Med, vol. 3, n. 12, dicembre 2006, pp. e528, DOI:10.1371/journal.pmed.0030528, PMID 17194200.
(EN) Vincenzo De Giorgi, Marta Grazzini e Silvia Benemei, Propranolol for Off-Label Treatment of Patients With Melanoma: Results From a Cohort Study, in JAMA Oncology, DOI:10.1001/jamaoncol.2017.2908. URL consultato il 3 ottobre 2017.

jamanetwork.com

(EN) Vincenzo De Giorgi, Marta Grazzini e Silvia Benemei, Propranolol for Off-Label Treatment of Patients With Melanoma: Results From a Cohort Study, in JAMA Oncology, DOI:10.1001/jamaoncol.2017.2908. URL consultato il 3 ottobre 2017.

nejm.org

content.nejm.org

Léauté-Labrèze C et al., Propranolol for Severe Hemangiomas of Infancy (PDF), in New England Journal of Medicine, vol. 358, 24 pagine=2649–2651, giugno 2008, DOI:10.1056/NEJMc0708819, PMID 18550886.

nih.gov

ncbi.nlm.nih.gov

Si era riscontrato che nei topi la somministrazione di pronetalolo era connessa con un'alta insorgenza di neoplasie maligne, specialmente linfosarcomi al timo. Si veda:
G.E. Paget, Carcinogenic action of pronethalol, in British Medical Journal, vol. 2, n. 5367, 16 novembre 1963, pp. 1266-7, PMID 14056902.
Per un confronto tra alcune delle proprietà del pronetalolo e del propranololo si veda:
J.W. Black, W A Duncan e R G Shanks, Comparison of some properties of pronethalol and propranolol, in British Journal of Pharmacology and Chemotherapy, vol. 25, n. 3, dicembre 1965, pp. 577-91, PMID 9142411.
Young R, Glennon RA, S(−)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats (PDF) ^{[collegamento interrotto]}, in Psychopharmacology, vol. 203, n. 2, aprile 2009, pp. 369-82, DOI:10.1007/s00213-008-1317-2, PMID 18795268.
Frank MJ, Abdulla AM, Watkins LO, Prisant L, Stefadouros MA, Long-term medical management of hypertrophic cardiomyopathy: usefulness of propranolol, in European heart journal, vol. 4, suppl. F, novembre 1983, pp. 155-64, DOI:10.1093/eurheartj/4.suppl_F.155, PMID 6686531.
Saenz de la Calzada C, Ziady GM, Hardarson T, Curiel R, Goodwin JF, Effect of acute administration of propranolol on ventricular function in hypertrophic obstructive cardiomyopathy measured by non-invasive techniques, in British heart journal, vol. 38, n. 8, agosto 1976, pp. 798-803, PMID 987791.
Chew SL, Recent developments in the therapy of phaeochromocytoma, in Expert Opin Investig Drugs, vol. 13, n. 12, dicembre 2004, pp. 1579-83, DOI:10.1517/13543784.13.12.1579, PMID 15566315.
Prichard BN, Ross EJ, Use of propranolol in conjunction with alpha receptor blocking drugs in pheochromocytoma, in American Journal of Cardiology, vol. 18, n. 3, settembre 1966, pp. 394-8, PMID 5925096.
McLarty DG, Brownlie BE, Alexander WD, Papapetrou PD, Horton P, Remission of thyrotoxicosis during treatment with propranolol, in British Medical Journal, vol. 2, n. 5862, 12 maggio 1973, pp. 332-4, PMC 1589280, PMID 4122248.
Haddad JF, Tibblin S, Preoperative treatment of thyrotoxicosis in developing countries: a comparative study of carbimazole and propranolol, in Ann R Coll Surg Engl, vol. 70, n. 6, novembre 1988, pp. 357-60, PMID 3207325.
Lee TC, Coffey RJ, Currier BM, Ma XP, Canary JJ, Propranolol and thyroidectomy in the treatment of thyrotoxicosis, in Annals of surgery, vol. 195, n. 6, giugno 1982, pp. 766-73, PMID 7082068.
Murray TJ, Treatment of essential tremor with propranolol, in Can Med Assoc J., vol. 107, n. 10, 18 novembre 1972, pp. 984-6, PMID 5082025.
(NO) Dietrichs E, Kvikstad V, [Essential tremor], in Tidsskr Nor Laegeforen, vol. 128, n. 19, 9 ottobre 2008, pp. 2210-3, PMID 18846147.
Gorman WP, Cooper R, Pocock P, Campbell MJ, A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis, in J Neurol Neurosurg Psychiatry, vol. 49, n. 1, gennaio 1986, pp. 64-8, PMID 3514797.
Cleeves L, Findley LJ, Beta-adrenoreceptor mechanisms in essential tremor: a comparative single dose study of the effect of a non-selective and a beta-2 selective adrenoreceptor antagonist, in J Neurol Neurosurg Psychiatry, vol. 47, n. 9, settembre 1984, pp. 976-82, PMID 6148382.
Graham EM, Bandisode VM, Bradley SM, Crawford FA Jr, Simsic JM, Atz AM, Effect of preoperative use of propranolol on postoperative outcome in patients with tetralogy of Fallot, in The American Journal of Cardiology, vol. 101, n. 5, 1º marzo 2008, pp. 693-5, DOI:10.1016/j.amjcard.2007.10.033, PMID 18308023.
Mahmoud AB, Tantawy AE, Kouatli AA, Baslaim GM, Propranolol: a new indication for an old drug in preventing postoperative junctional ectopic tachycardia after surgical repair of tetralogy of Fallot (PDF) ^{[collegamento interrotto]}, in Interact Cardiovasc Thorac Surg, vol. 7, n. 2, aprile 2008, pp. 184-7, DOI:10.1510/icvts.2007.160945, PMID 18089616.
Ohrström A, Pandolfi M, Long-term treatment of glaucoma with systemic propranolol, in Am J Ophthalmol, vol. 86, n. 3, settembre 1978, pp. 340-4, PMID 717497.
Borthne A, The treatment of glaucoma with propranolol (Inderal). A clinical trial., in Acta Ophthalmologica, vol. 54, n. 3, luglio 1976, pp. 291-300, PMID 782144.
Elman MJ, Sugar J, Fiscella R, et al., The effect of propranolol versus placebo on resident surgical performance, in Transactions of the American Ophthalmological Society, vol. 96, 1998, pp. 283–91; discussion 291–4, PMC 1298399, PMID 10360293.
Sharma A, Madaan V, Petty F, Propranolol treatment for neuroleptic-induced akathisia, in Prim Care Companion J Clin Psychiatry, vol. 7, n. 4, 2005, pp. 202-3, PMID 16163405.
Kramer MS, Gorkin R, DiJohnson C, Treatment of neuroleptic-induced akathisia with propranolol: a controlled replication study, in The Hillside Journal of Clinical Psychiatry, vol. 11, n. 2, 1989, pp. 107-19, PMID 2577308.
Koller WC, Herbster G, Adjuvant therapy of parkinsonian tremor, in Archives of neurology, vol. 44, n. 9, settembre 1987, pp. 921-3, PMID 3619710.
Strang RR, Clinical trial with a beta-receptor antagonist (propranolol) in parkinsonism, in J Neurol Neurosurg Psychiatry, vol. 28, n. 5, ottobre 1965, pp. 404-6, PMID 5839555.
Léauté-Labrèze C et al., Propranolol for Severe Hemangiomas of Infancy (PDF), in New England Journal of Medicine, vol. 358, 24 pagine=2649–2651, giugno 2008, DOI:10.1056/NEJMc0708819, PMID 18550886.
(DE) Kornischka J, Cordes J, Agelink MW, [40 years beta-adrenoceptor blockers in psychiatry], in Fortschr Neurol Psychiatr., vol. 75, n. 4, aprile 2007, pp. 199-210, DOI:10.1055/s-2006-944295, PMID 17200914.
Vieweg V, Pandurangi A, Levenson J, Silverman J, The consulting psychiatrist and the polydipsia-hyponatremia syndrome in schizophrenia, in Int J Psychiatry Med, vol. 24, n. 4, 1994, pp. 275–303, PMID 7737786.
Kishi Y, Kurosawa H, Endo S, Is propranolol effective in primary polydipsia?, in Int J Psychiatry Med, vol. 28, n. 3, 1998, pp. 315–25, PMID 9844835.
Goldstein MB, Folsom T, The successful treatment of psychogenic polydipsia and water intoxication with propranolol. A case report, in Minnesota medicine, vol. 74, n. 4, aprile 1991, pp. 29-32, PMID 1875874.
(FR) Thibaut F, Colonna L, [Anti-aggressive effect of beta-blockers], in Encephale, vol. 19, n. 3, 1993, pp. 263–7, PMID 7903928.
Fleminger S, Greenwood RJ, Oliver DL, Pharmacological management for agitation and aggression in people with acquired brain injury, in Cochrane Database Syst Rev, n. 4, 18 ottobre 2006, DOI:10.1002/14651858.CD003299.pub2, PMID 17054165.
Brunet A, Orr SP, Tremblay J, Robertson K, Nader K, Pitman RK, Effect of post-retrieval propranolol on psychophysiologic responding during subsequent script-driven traumatic imagery in post-traumatic stress disorder, in Journal of Psychiatric Research, vol. 42, n. 6, maggio 2008, pp. 503-6, DOI:10.1016/j.jpsychires.2007.05.006, PMID 17588604.
Vaiva G, Ducrocq F, Jezequel K, Averland B, Lestavel P, Brunet A, Marmar CR, Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma, in Biological psychiatry, vol. 54, n. 9, 1º novembre 2003, pp. 947-9, DOI:10.1016/S0006-3223(03)00412-8, PMID 14573324.
McGhee LL, Maani CV, Garza TH, Desocio PA, Gaylord KM, Black IH, The effect of propranolol on posttraumatic stress disorder in burned service members, in J Burn Care Res, vol. 30, n. 1, gennaio-febbraio 2009, pp. 92-7, PMID 19060728.
Glannon W, Psychopharmacology and memory, in Journal of Medical Ethics, vol. 32, n. 2, pp. 74-8, DOI:10.1136/jme.2005.012575, PMID 16446410.
Ohnishi S, Sadanaga K, Katsuoka M, Weidanz W, Effects of membrane acting-drugs on plasmodium species and sickle cell erythrocytes, in Mol Cell Biochem, vol. 91, n. 1-2, 1990, pp. 159–65, DOI:10.1007/BF00228091, PMID 2695829.
Singh N, Puri S, Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis, in Acta Trop, vol. 77, n. 2, 2000, pp. 185–93, DOI:10.1016/S0001-706X(00)00133-9, PMID 11080509.
Murphy S, Harrison T, Hamm H, Lomasney J, Mohandas N, Haldar K, Erythrocyte G protein as a novel target for malarial chemotherapy, in PLoS Med, vol. 3, n. 12, dicembre 2006, pp. e528, DOI:10.1371/journal.pmed.0030528, PMID 17194200.
La fluvoxamina rallenta il metabolismo del propranololo, portando quindi a livelli ematici di propranololo superiori alla norma. van Harten J, Overview of the pharmacokinetics of fluvoxamine, in Clin Pharmacokinet, 29 Suppl 1, 1995, pp. 1–9, PMID 8846617.

pubmedcentral.nih.gov

Si era riscontrato che nei topi la somministrazione di pronetalolo era connessa con un'alta insorgenza di neoplasie maligne, specialmente linfosarcomi al timo. Si veda:
G.E. Paget, Carcinogenic action of pronethalol, in British Medical Journal, vol. 2, n. 5367, 16 novembre 1963, pp. 1266-7, PMID 14056902.
Per un confronto tra alcune delle proprietà del pronetalolo e del propranololo si veda:
J.W. Black, W A Duncan e R G Shanks, Comparison of some properties of pronethalol and propranolol, in British Journal of Pharmacology and Chemotherapy, vol. 25, n. 3, dicembre 1965, pp. 577-91, PMID 9142411.
Saenz de la Calzada C, Ziady GM, Hardarson T, Curiel R, Goodwin JF, Effect of acute administration of propranolol on ventricular function in hypertrophic obstructive cardiomyopathy measured by non-invasive techniques, in British heart journal, vol. 38, n. 8, agosto 1976, pp. 798-803, PMID 987791.
Haddad JF, Tibblin S, Preoperative treatment of thyrotoxicosis in developing countries: a comparative study of carbimazole and propranolol, in Ann R Coll Surg Engl, vol. 70, n. 6, novembre 1988, pp. 357-60, PMID 3207325.
Lee TC, Coffey RJ, Currier BM, Ma XP, Canary JJ, Propranolol and thyroidectomy in the treatment of thyrotoxicosis, in Annals of surgery, vol. 195, n. 6, giugno 1982, pp. 766-73, PMID 7082068.
Murray TJ, Treatment of essential tremor with propranolol, in Can Med Assoc J., vol. 107, n. 10, 18 novembre 1972, pp. 984-6, PMID 5082025.
Gorman WP, Cooper R, Pocock P, Campbell MJ, A comparison of primidone, propranolol, and placebo in essential tremor, using quantitative analysis, in J Neurol Neurosurg Psychiatry, vol. 49, n. 1, gennaio 1986, pp. 64-8, PMID 3514797.
Cleeves L, Findley LJ, Beta-adrenoreceptor mechanisms in essential tremor: a comparative single dose study of the effect of a non-selective and a beta-2 selective adrenoreceptor antagonist, in J Neurol Neurosurg Psychiatry, vol. 47, n. 9, settembre 1984, pp. 976-82, PMID 6148382.
Sharma A, Madaan V, Petty F, Propranolol treatment for neuroleptic-induced akathisia, in Prim Care Companion J Clin Psychiatry, vol. 7, n. 4, 2005, pp. 202-3, PMID 16163405.
Strang RR, Clinical trial with a beta-receptor antagonist (propranolol) in parkinsonism, in J Neurol Neurosurg Psychiatry, vol. 28, n. 5, ottobre 1965, pp. 404-6, PMID 5839555.
Glannon W, Psychopharmacology and memory, in Journal of Medical Ethics, vol. 32, n. 2, pp. 74-8, DOI:10.1136/jme.2005.012575, PMID 16446410.
Murphy S, Harrison T, Hamm H, Lomasney J, Mohandas N, Haldar K, Erythrocyte G protein as a novel target for malarial chemotherapy, in PLoS Med, vol. 3, n. 12, dicembre 2006, pp. e528, DOI:10.1371/journal.pmed.0030528, PMID 17194200.

oadoi.org

Frank MJ, Abdulla AM, Watkins LO, Prisant L, Stefadouros MA, Long-term medical management of hypertrophic cardiomyopathy: usefulness of propranolol, in European heart journal, vol. 4, suppl. F, novembre 1983, pp. 155-64, DOI:10.1093/eurheartj/4.suppl_F.155, PMID 6686531.
Chew SL, Recent developments in the therapy of phaeochromocytoma, in Expert Opin Investig Drugs, vol. 13, n. 12, dicembre 2004, pp. 1579-83, DOI:10.1517/13543784.13.12.1579, PMID 15566315.
Graham EM, Bandisode VM, Bradley SM, Crawford FA Jr, Simsic JM, Atz AM, Effect of preoperative use of propranolol on postoperative outcome in patients with tetralogy of Fallot, in The American Journal of Cardiology, vol. 101, n. 5, 1º marzo 2008, pp. 693-5, DOI:10.1016/j.amjcard.2007.10.033, PMID 18308023.
(DE) Kornischka J, Cordes J, Agelink MW, [40 years beta-adrenoceptor blockers in psychiatry], in Fortschr Neurol Psychiatr., vol. 75, n. 4, aprile 2007, pp. 199-210, DOI:10.1055/s-2006-944295, PMID 17200914.
Fleminger S, Greenwood RJ, Oliver DL, Pharmacological management for agitation and aggression in people with acquired brain injury, in Cochrane Database Syst Rev, n. 4, 18 ottobre 2006, DOI:10.1002/14651858.CD003299.pub2, PMID 17054165.
Vaiva G, Ducrocq F, Jezequel K, Averland B, Lestavel P, Brunet A, Marmar CR, Immediate treatment with propranolol decreases posttraumatic stress disorder two months after trauma, in Biological psychiatry, vol. 54, n. 9, 1º novembre 2003, pp. 947-9, DOI:10.1016/S0006-3223(03)00412-8, PMID 14573324.
Ohnishi S, Sadanaga K, Katsuoka M, Weidanz W, Effects of membrane acting-drugs on plasmodium species and sickle cell erythrocytes, in Mol Cell Biochem, vol. 91, n. 1-2, 1990, pp. 159–65, DOI:10.1007/BF00228091, PMID 2695829.
Singh N, Puri S, Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis, in Acta Trop, vol. 77, n. 2, 2000, pp. 185–93, DOI:10.1016/S0001-706X(00)00133-9, PMID 11080509.

springerlink.com

Young R, Glennon RA, S(−)Propranolol as a discriminative stimulus and its comparison to the stimulus effects of cocaine in rats (PDF) ^{[collegamento interrotto]}, in Psychopharmacology, vol. 203, n. 2, aprile 2009, pp. 369-82, DOI:10.1007/s00213-008-1317-2, PMID 18795268.

tidsskriftet.no

(NO) Dietrichs E, Kvikstad V, [Essential tremor], in Tidsskr Nor Laegeforen, vol. 128, n. 19, 9 ottobre 2008, pp. 2210-3, PMID 18846147.